Market Cap 1.34B
Revenue (ttm) 862.40M
Net Income (ttm) -212.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.60%
Debt to Equity Ratio 0.46
Volume 166,000
Avg Vol 149,208
Day's Range N/A - N/A
Shares Out 355.11M
Stochastic %K 0%
Beta 1.66
Analysts Sell
Price Target $6.00

Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, fibrosis, immunology, pain and inflammation, infectious, kidney, liver, rare, respiratory, fibrotic and metabolic disease; central nervous system (CNS) and cardio metab...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 49 40 560 81 0
Address:
Essener Bogen 7, Hamburg, Germany
ChartBandit02
ChartBandit02 May. 27 at 2:01 PM
$EVO oh no
0 · Reply
ChartBandit02
ChartBandit02 May. 27 at 12:04 PM
$EVO so why is it going straight down now ?
0 · Reply
witdiligence
witdiligence May. 26 at 9:38 AM
$EVO $EVVTY it's a matter of waiting for the tide to turn. The company has a strong moat and feels like a no-brainer at these levels. It reminds me of $DKNG, which traded near all-time lows for a while before staging a strong comeback—despite social media outrage over the CEO’s use of the company jet for personal trips and widespread calls to short the stock to zero. The only arguments that matter should always be: LEADERSHIP - EXECUTION - PRODUCT As long as they align, it is only a matter of time.
2 · Reply
ChartBandit02
ChartBandit02 May. 23 at 5:02 PM
$EVO do we think it will go any further
0 · Reply
LewisDaKat
LewisDaKat Apr. 17 at 5:55 PM
$EVO News Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results https://marketwirenews.com/news-releases/evotec-se-unveils-new-strategy-and-provides-2025-gui-7796617356173715.html $EVO
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 17 at 12:40 PM
$EVO (+8.6% pre) Evotec SE reports Q4 results; initiates outlook for FY25 and FY28 https://ooc.bz/l/62127
0 · Reply
briefingcom
briefingcom Apr. 17 at 12:09 PM
Gapping up: $QURE +44.4% $HTZ +16.8% $LBRT +9.4% $EVO +8.3%
0 · Reply
JasonInsightMarkets
JasonInsightMarkets Apr. 15 at 7:18 AM
$EVO CEO guides 66% to 68% EBITDA margin for 2025 in todays year-end report.
0 · Reply
PenkeTrading
PenkeTrading Mar. 7 at 9:56 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Evotec SE ADR. Is that bullish or bearish? $EVO #RsiOversold #NASDAQ
0 · Reply
jParkz
jParkz Mar. 5 at 12:00 AM
News out $EVO Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb https://marketwirenews.com/news-releases/evotec-announces-key-progress-in-neuroscience-collab-6145444038241616.html $EVO
0 · Reply
Latest News on EVO
Evotec SE (EVO) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:15 AM EDT - 6 weeks ago

Evotec SE (EVO) Q1 2025 Earnings Call Transcript


Evotec SE (EVO) Q4 2024 Earnings Call Transcript

Apr 17, 2025, 2:24 PM EDT - 2 months ago

Evotec SE (EVO) Q4 2024 Earnings Call Transcript


Evotec Announces Change in Management Board

Feb 26, 2025, 2:00 AM EST - 4 months ago

Evotec Announces Change in Management Board


Evotec: Some Recovery Has Come, But Much More Is Expected

Dec 29, 2024, 12:30 PM EST - 6 months ago

Evotec: Some Recovery Has Come, But Much More Is Expected


Comment on Withdrawn Non-Binding Offer

Nov 22, 2024, 11:15 AM EST - 7 months ago

Comment on Withdrawn Non-Binding Offer


Halozyme withdraws $2.1 bln buyout offer for Evotec

Nov 22, 2024, 8:55 AM EST - 7 months ago

Halozyme withdraws $2.1 bln buyout offer for Evotec

HALO


Halozyme CEO: Evotec Is Poised for Growth

Nov 18, 2024, 4:00 PM EST - 7 months ago

Halozyme CEO: Evotec Is Poised for Growth

HALO


Comment on Media Report

Nov 14, 2024, 5:30 PM EST - 7 months ago

Comment on Media Report


Evotec SE (EVO) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 7:11 PM EST - 8 months ago

Evotec SE (EVO) Q3 2024 Earnings Call Transcript


Evotec and Bristol Myers Squibb Expand Proteomics Partnership

Oct 23, 2024, 2:00 AM EDT - 8 months ago

Evotec and Bristol Myers Squibb Expand Proteomics Partnership


Evotec: Weak Performance, But Long-Term Potential Is There

Aug 30, 2024, 10:15 AM EDT - 10 months ago

Evotec: Weak Performance, But Long-Term Potential Is There


Evotec SE (EVO) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 12:36 PM EDT - 11 months ago

Evotec SE (EVO) Q2 2024 Earnings Call Transcript


Evotec SE Reports First Half-year 2024 Results on 14 August 2024

Aug 7, 2024, 7:15 AM EDT - 11 months ago

Evotec SE Reports First Half-year 2024 Results on 14 August 2024


Evotec Provides Guidance Update

Aug 6, 2024, 3:30 PM EDT - 11 months ago

Evotec Provides Guidance Update


Evotec SE Provides Guidance Update

Aug 6, 2024, 3:15 PM EDT - 11 months ago

Evotec SE Provides Guidance Update


Evotec SE: Results of the Annual General Meeting 2024

Jun 10, 2024, 12:15 PM EDT - 1 year ago

Evotec SE: Results of the Annual General Meeting 2024


Evotec SE (EVO) Q1 2024 Earnings Call Transcript

May 22, 2024, 3:23 PM EDT - 1 year ago

Evotec SE (EVO) Q1 2024 Earnings Call Transcript


ChartBandit02
ChartBandit02 May. 27 at 2:01 PM
$EVO oh no
0 · Reply
ChartBandit02
ChartBandit02 May. 27 at 12:04 PM
$EVO so why is it going straight down now ?
0 · Reply
witdiligence
witdiligence May. 26 at 9:38 AM
$EVO $EVVTY it's a matter of waiting for the tide to turn. The company has a strong moat and feels like a no-brainer at these levels. It reminds me of $DKNG, which traded near all-time lows for a while before staging a strong comeback—despite social media outrage over the CEO’s use of the company jet for personal trips and widespread calls to short the stock to zero. The only arguments that matter should always be: LEADERSHIP - EXECUTION - PRODUCT As long as they align, it is only a matter of time.
2 · Reply
ChartBandit02
ChartBandit02 May. 23 at 5:02 PM
$EVO do we think it will go any further
0 · Reply
LewisDaKat
LewisDaKat Apr. 17 at 5:55 PM
$EVO News Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results https://marketwirenews.com/news-releases/evotec-se-unveils-new-strategy-and-provides-2025-gui-7796617356173715.html $EVO
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 17 at 12:40 PM
$EVO (+8.6% pre) Evotec SE reports Q4 results; initiates outlook for FY25 and FY28 https://ooc.bz/l/62127
0 · Reply
briefingcom
briefingcom Apr. 17 at 12:09 PM
Gapping up: $QURE +44.4% $HTZ +16.8% $LBRT +9.4% $EVO +8.3%
0 · Reply
JasonInsightMarkets
JasonInsightMarkets Apr. 15 at 7:18 AM
$EVO CEO guides 66% to 68% EBITDA margin for 2025 in todays year-end report.
0 · Reply
PenkeTrading
PenkeTrading Mar. 7 at 9:56 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Evotec SE ADR. Is that bullish or bearish? $EVO #RsiOversold #NASDAQ
0 · Reply
jParkz
jParkz Mar. 5 at 12:00 AM
News out $EVO Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb https://marketwirenews.com/news-releases/evotec-announces-key-progress-in-neuroscience-collab-6145444038241616.html $EVO
0 · Reply
WhisperNumber
WhisperNumber Feb. 12 at 8:05 PM
$TXG #earnings after close, the expectation from the WhisperNumber community is -$0.28, 2c ahead of analyst estimates. Implied move +/-12.9%. https://www.whispernumber.com/wr_alerts.jsp #options #trade $FTRE $EVO $BLFS
0 · Reply
monkeysun
monkeysun Jan. 18 at 11:49 PM
0 · Reply
WireX
WireX Jan. 2 at 3:56 PM
$EVO - Evotec tells Halozyme that $5.50 offer is not in the ballpark for fair valuation no need to talk about a buyout if you aren't serious. . Chart is a mess for EVO but the long term investors got a nice insight into operations and what the future holds. Got my starter position and look to add. Investing not day trading here.
0 · Reply
EthelWhittingham980
EthelWhittingham980 Dec. 16 at 4:01 PM
$EVO AITX’s ROAMEO Gen 4 advances mobile security robotics, bringing industry-leading innovation in February 2025.
0 · Reply
smartkarma
smartkarma Nov. 29 at 4:05 AM
Aggregated Monthly Average Player Numbers #chartoftheday (via Quartr_App) Great data from Alinea Analytics showing the growth of average monthly player numbers over for years for $EVO, Pragmatic Play and Playtech. -- $SPY $NIFTY50.NSE
0 · Reply
BuyNow_SellLater
BuyNow_SellLater Nov. 28 at 2:45 AM
$EVO if you turn down the offer, your quarterly results better back that up. We shall see
0 · Reply
BarbarianTrades
BarbarianTrades Nov. 27 at 7:35 PM
$XERS M&A speculation moving the stock after $HALO backs out of 1.5B $EVO deal is my guess
2 · Reply
jParkz
jParkz Nov. 22 at 11:30 PM
$EVO $EVO Nhttps://marketwirenews.com/news-releases/comment-on-withdrawn-non-binding-offer-4928520765371456.html ews out Comment on Withdrawn Non-Binding Offer
0 · Reply
LewisDaKat
LewisDaKat Nov. 22 at 11:25 PM
News $EVO Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions https://marketwirenews.com/news-releases/halozyme-withdraws-proposal-to-acquire-evotec-follow-7207072229975864.html $EVO
0 · Reply